{"symbol":"ABBV","provider":"yahoo-finance","fetchedAt":"2025-12-24T09:17:14.206Z","asOfDate":"2025-12-24","articles":[{"id":"d6771ef1-754e-383c-8d5e-29d22a50f38c","title":"2 Dividend Kings Quietly Beating the Market This Year","url":"https://finance.yahoo.com/m/d6771ef1-754e-383c-8d5e-29d22a50f38c/2-dividend-kings-quietly.html","publisher":"Barchart","publishedAt":"2025-12-24T00:30:02.000Z","relatedTickers":["^GSPC"],"mainIdea":"2 Dividend Kings Quietly Beating the Market This Year","summary":"Barchart: 2 Dividend Kings Quietly Beating the Market This Year. These two are the calm outperformers that might have been overlooked. Related tickers mentioned: ^GSPC."},{"id":"51c22cfd-2655-30f7-8e08-df4b73fd6e3a","title":"ABBV vs. AZN: Which Pharma Stock is the Better Investment Now?","url":"https://finance.yahoo.com/news/abbv-vs-azn-pharma-stock-155100815.html","publisher":"Zacks","publishedAt":"2025-12-23T15:51:00.000Z","relatedTickers":["AZN"],"mainIdea":"ABBV vs. AZN: Which Pharma Stock is the Better Investment Now?","summary":"Zacks: ABBV vs. AZN: Which Pharma Stock is the Better Investment Now?. AbbVie and AstraZeneca both bring blockbuster drugs, deep pipelines and risks, but their growth paths, pressures and priorities now sharply diverge. Related tickers mentioned: AZN."},{"id":"365f8e8a-12dd-3afc-b85f-9a89dded47c3","title":"5 Big Drug Stocks That May Continue to Outperform in 2026","url":"https://finance.yahoo.com/news/5-big-drug-stocks-may-134800671.html","publisher":"Zacks","publishedAt":"2025-12-23T13:48:00.000Z","relatedTickers":["JNJ","LLY","^GSPC"],"mainIdea":"5 Big Drug Stocks That May Continue to Outperform in 2026","summary":"Zacks: 5 Big Drug Stocks That May Continue to Outperform in 2026. Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026. Related tickers mentioned: JNJ, LLY, ^GSPC."}]}
